- Home
- BFS vs QURE Comparison
BFS vs QURE Comparison
Compare BFS & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFS
- QURE
- Stock Information
- Founded
- BFS 1993
- QURE 1998
- Country
- BFS United States
- QURE Netherlands
- Employees
- BFS N/A
- QURE N/A
- Industry
- BFS Real Estate Investment Trusts
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- BFS Real Estate
- QURE Health Care
- Exchange
- BFS Nasdaq
- QURE Nasdaq
- Market Cap
- BFS 828.5M
- QURE 866.3M
- IPO Year
- BFS 1993
- QURE 2007
- Fundamental
- Price
- BFS $33.94
- QURE $16.33
- Analyst Decision
- BFS
- QURE Strong Buy
- Analyst Count
- BFS 0
- QURE 10
- Target Price
- BFS N/A
- QURE $36.90
- AVG Volume (30 Days)
- BFS 53.4K
- QURE 814.7K
- Earning Date
- BFS 08-07-2025
- QURE 07-29-2025
- Dividend Yield
- BFS 6.91%
- QURE N/A
- EPS Growth
- BFS N/A
- QURE N/A
- EPS
- BFS 1.32
- QURE N/A
- Revenue
- BFS $277,902,000.00
- QURE $14,337,000.00
- Revenue This Year
- BFS $10.48
- QURE N/A
- Revenue Next Year
- BFS $6.52
- QURE $301.10
- P/E Ratio
- BFS $25.89
- QURE N/A
- Revenue Growth
- BFS 5.23
- QURE N/A
- 52 Week Low
- BFS $31.25
- QURE $4.45
- 52 Week High
- BFS $42.39
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- BFS 58.45
- QURE 63.97
- Support Level
- BFS $33.58
- QURE $15.28
- Resistance Level
- BFS $34.23
- QURE $16.68
- Average True Range (ATR)
- BFS 0.54
- QURE 0.79
- MACD
- BFS 0.17
- QURE 0.13
- Stochastic Oscillator
- BFS 85.87
- QURE 87.59
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.